Future research should be directed to emerging immuno-thrombotic markers shown to be important in the diagnosis of cardiac diseases such as D-dimer and P-selectin [362–364], where electrochemical methods are currently limited [365–370]. This evidence concerns the gene SELP and heart disorder.